This is an old revision of this page, as edited by Beetstra (talk | contribs) at 20:06, 16 February 2012 (Saving copy of the {{drugbox}} taken from revid 472597743 of page Adalimumab for the Chem/Drugbox validation project (updated: 'DrugBank', 'ChEMBL').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 20:06, 16 February 2012 by Beetstra (talk | contribs) (Saving copy of the {{drugbox}} taken from revid 472597743 of page Adalimumab for the Chem/Drugbox validation project (updated: 'DrugBank', 'ChEMBL').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) | This page contains a copy of the infobox ({{drugbox}}) taken from revid 472597743 of page Adalimumab with values updated to verified values. |
 | |
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | TNF alpha |
| Clinical data | |
| Trade names | Humira |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a603010 |
| Pregnancy category |
|
| Routes of administration | Subcutaneous |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | 64% (subcutaneous), 0% (oral) |
| Elimination half-life | 10–20 days. |
| Identifiers | |
| CAS Number | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Formula | C6428H9912N1694O1987S46 |
| Molar mass | 144190.3 g/mol g·mol |
| (what is this?) (verify) | |
